PARTICIPATE IN FORTITUDE-ALS
FORTITUDE-ALS is a clinical trial of an investigational oral drug for the treatment of amyotrophic lateral sclerosis (ALS). This clinical trial is now enrolling participants in both the United States and Canada.
WHO: Adults diagnosed with ALS within the last 24 months
WHERE: Locations in the United States and Canada
TRAVEL EXPENSES: Qualified participants may receive travel reimbursement
PLEASE COMPLETE THIS FORM TO BE CONSIDERED FOR PARTICIPATION: